- Home
- ALLR vs ERNA Comparison
ALLR vs ERNA Comparison
Compare ALLR & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- ERNA
- Stock Information
- Founded
- ALLR 2004
- ERNA 2018
- Country
- ALLR United States
- ERNA United States
- Employees
- ALLR N/A
- ERNA N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- ALLR Health Care
- ERNA Health Care
- Exchange
- ALLR Nasdaq
- ERNA Nasdaq
- Market Cap
- ALLR 15.8M
- ERNA 13.5M
- IPO Year
- ALLR N/A
- ERNA N/A
- Fundamental
- Price
- ALLR $1.01
- ERNA $1.56
- Analyst Decision
- ALLR Strong Buy
- ERNA
- Analyst Count
- ALLR 1
- ERNA 0
- Target Price
- ALLR $9.00
- ERNA N/A
- AVG Volume (30 Days)
- ALLR 536.3K
- ERNA 89.4K
- Earning Date
- ALLR 08-08-2025
- ERNA 08-12-2025
- Dividend Yield
- ALLR N/A
- ERNA N/A
- EPS Growth
- ALLR N/A
- ERNA N/A
- EPS
- ALLR N/A
- ERNA N/A
- Revenue
- ALLR N/A
- ERNA $535,000.00
- Revenue This Year
- ALLR N/A
- ERNA N/A
- Revenue Next Year
- ALLR N/A
- ERNA N/A
- P/E Ratio
- ALLR N/A
- ERNA N/A
- Revenue Growth
- ALLR N/A
- ERNA 365.22
- 52 Week Low
- ALLR $0.61
- ERNA $1.53
- 52 Week High
- ALLR $6.00
- ERNA $29.25
- Technical
- Relative Strength Index (RSI)
- ALLR 49.17
- ERNA 31.48
- Support Level
- ALLR $1.03
- ERNA $1.71
- Resistance Level
- ALLR $1.17
- ERNA $2.57
- Average True Range (ATR)
- ALLR 0.08
- ERNA 0.21
- MACD
- ALLR -0.00
- ERNA -0.01
- Stochastic Oscillator
- ALLR 28.89
- ERNA 3.35
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.